Vera Therapeutics (VERA) Cash from Operations (2020 - 2026)
Vera Therapeutics (VERA) posted Cash from Operations of 106500000.0 for Q1 2026, down 52.16% on a QoQ basis from 69994000.0 in Q4 2025, and down 95.75% year-over-year from 2506158737.02 in Q1 2025.
Vera Therapeutics (VERA) Cash from Operations (2020 - 2026) Analysis & Trends
Vera Therapeutics' Cash from Operations history runs 7 years deep, the most recent figure standing at 106500000.0 for Q1 2026.
- Quarterly Cash from Operations fell 95.75% year-over-year to 106500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 293198000.0 (down 88.85% YoY) and the FY2025 annual result came in at 241104000.0, down 79.02% from the prior year.
- Cash from Operations was 106500000.0 for Q1 2026 at Vera Therapeutics, down from 69994000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8981000.0 in Q1 2022 and bottomed at 106500000.0 in Q1 2026.
- A 5-year average of 37768235.29 and a median of 26292000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 235.89% — and 2023, when it increased 6.63%.
- Vera Therapeutics' Cash from Operations stood at 21162000.0 in 2022, then decreased by 18.82% to 25144000.0 in 2023, then sank by 55.83% to 39182000.0 in 2024, then slumped by 78.64% to 69994000.0 in 2025, then tumbled by 52.16% to 106500000.0 in 2026.
- Business Quant data shows VERA's Cash from Operations at 106500000.0 in Q1 2026, 69994000.0 in Q4 2025, and 61906000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -106.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.50 Mn |
| Mar 31, 2026 | -106.50 Mn |
| Dec 31, 2025 | -69.99 Mn |
| Dec 31, 2025 | -69.99 Mn |
| Sep 30, 2025 | -61.91 Mn |
| Sep 30, 2025 | -61.91 Mn |
| Jun 30, 2025 | -54.80 Mn |
| Jun 30, 2025 | -54.80 Mn |
| Mar 31, 2025 | -54.41 Mn |
| Mar 31, 2025 | -54.41 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Sep 30, 2024 | -36.89 Mn |
| Sep 30, 2024 | -36.89 Mn |
| Jun 30, 2024 | -24.78 Mn |
| Jun 30, 2024 | -24.78 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Dec 31, 2023 | -25.14 Mn |
| Dec 31, 2023 | -25.14 Mn |